Literature DB >> 15664904

Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens.

L Jeannine Brady1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15664904      PMCID： PMC547018          DOI： 10.1128/IAI.73.2.671-678.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  130 in total

1.  What is a pathogen?

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

2.  Prevention of colonization of Streptococcus mutans by topical application of monoclonal antibodies in human subjects.

Authors:  J K Ma; T Lehner
Journal:  Arch Oral Biol       Date:  1990       Impact factor: 2.633

3.  Cellular immune response to the antigen administered as an immune complex in vivo.

Authors:  S Marusić-Galesić; M Marusić; B Pokrić
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

4.  Cellular immune response to the antigen administered as an immune complex.

Authors:  S Marusić-Galesić; K Pavelić; B Pokrić
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

5.  Immune complexes as immunizing agents to increase the number of monoclonal antibody producing hybrids and to deviate the response to poorly immunogenic epitopes.

Authors:  P Bouige; S Iscaki; J Pillot
Journal:  Hybridoma       Date:  1990-12

Review 6.  Interference of monoclonal antibodies with proteolysis of antigens in cellular and in acellular systems.

Authors:  F Manca
Journal:  Ann Ist Super Sanita       Date:  1991       Impact factor: 1.663

7.  Immune complex-mediated antigen presentation induces tumor immunity.

Authors:  Khadija Rafiq; Amy Bergtold; Raphael Clynes
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

8.  Kinetic immunodominance: functionally competing antibodies against exposed and cryptic epitopes of Escherichia coli beta-galactosidase are produced in time sequence.

Authors:  A Kunkl; D Fenoglio; F Manca; G Li Pira; C Cambiaggi; R Strom; F Celada
Journal:  Int Immunol       Date:  1992-06       Impact factor: 4.823

9.  Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen.

Authors:  T Hanke; P Szawlowski; R E Randall
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

10.  Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies.

Authors:  F Manca; D Fenoglio; G Li Pira; A Kunkl; F Celada
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307
View more
  31 in total

Review 1.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

2.  Potent In Vitro and In Vivo Activity of Plantibody Specific for Porphyromonas gingivalis FimA.

Authors:  Young-Suk Choi; Ji-Hoi Moon; Tae-Geum Kim; Jin-Yong Lee
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

3.  An HIV Envelope gp120-Fc Fusion Protein Elicits Effector Antibody Responses in Rhesus Macaques.

Authors:  Zhanna Shubin; Weizhong Li; Bhawna Poonia; Guido Ferrari; Celia LaBranche; David Montefiori; Xiaoping Zhu; C David Pauza
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

4.  A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection.

Authors:  Sandra G Morrison; Richard P Morrison
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

5.  SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy.

Authors:  Arturo Casadevall; Michael J Joyner; Liise-Anne Pirofski
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

6.  A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

7.  Molecular cloning and expression of the porcine high-affinity immunoglobulin G Fc receptor (FcgammaRI).

Authors:  Gaiping Zhang; Songlin Qiao; Qingmei Li; Xuannian Wang; Yanhua Duan; Li Wang; Zhijun Xiao; Chun Xia
Journal:  Immunogenetics       Date:  2006-08-16       Impact factor: 2.846

8.  A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy.

Authors:  Henri-Alexandre Michaud; Tiphanie Gomard; Laurent Gros; Kevin Thiolon; Roudaina Nasser; Chantal Jacquet; Javier Hernandez; Marc Piechaczyk; Mireia Pelegrin
Journal:  PLoS Pathog       Date:  2010-06-10       Impact factor: 6.823

9.  Immunobiological outcomes of repeated chlamydial infection from two models of within-host population dynamics.

Authors:  David M Vickers; Qian Zhang; Nathaniel D Osgood
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

10.  Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation.

Authors:  Tri Giang Phan; Jesse A Green; Elizabeth E Gray; Ying Xu; Jason G Cyster
Journal:  Nat Immunol       Date:  2009-06-07       Impact factor: 25.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.